Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells

Cancer Research

Volumn 63, Issue 9, 2003, Pages 2127-2133

  Su, Zhen ^a   Dannull, Jens ^a   Heiser, Axel ^a   Yancey, Donna ^a   Pruitt, Scott ^a   Madden, John ^a   Coleman, Doris ^a   Niedzwiecki, Donna ^a   Gilboa, Eli ^a   Vieweg, Johannes ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; ONCOFETAL ANTIGEN; RNA DIRECTED DNA POLYMERASE; RNA TRANSFECTED DENDRITIC CELL; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANEMIA; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CANCER IMMUNIZATION; CANCER MORTALITY; CLINICAL TRIAL; DENDRITIC CELL; DRUG EFFICACY; DRUG SAFETY; DRUG TOXICITY; DYSPNEA; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNITY; KIDNEY CANCER; KIDNEY PARENCHYMA; MALE; METASTASIS; PATIENT; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINATION;

CANCER VACCINES; CARCINOMA, RENAL CELL; DENDRITIC CELLS; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; KIDNEY NEOPLASMS; MALE; RNA, NEOPLASM; T-LYMPHOCYTES; TELOMERASE; TRANSFECTION;

EID: 0038066552     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1998. CA Cancer J. Clin., 48: 6-29, 1998.
2. Holtl, L., Rieser, C., Papesh, C., Ramoner, R., Herold, M., Klocker, H., Radmayr, C., Stenzl, A., Bartsch, G., and Thurnher, M. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J. Urol., 161: 777-782, 1999.
3. Fong, L., and Engleman, E. G. Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol., 18: 245-273, 2000.
4. Raychaudhuri, S., and Rock, K. L. Fully mobilizing host defense: building better vaccines. Nat. Biotechnol., 16: 1025-1031, 1998.
5. Heiser, A., Dahm, P., Maurice, M., Yancey, D., and Vieweg, J. Human dendritic cells pulsed with renal tumor RNA stimulate tumor specific CTL in vitro without inducing autoimmune toxicity. Cancer Res., 61: 411-419, 2001.
6. Heiser, A., Maurice, M. A., Yancey, D. R., Dahm, P., Pruitt, S. K., Boczkowski, D., Nair, S. K., Ballo, M. S., Gilboa, E., and Vieweg, J. Induction of polyclonal prostate cancer specific cytotoxic T lymphocytes using dendritic cells transfected with amplified tumor RNA. J. Immunol., 166: 2953-2960, 2001.
7. Heiser, A., Coleman, D. M., Dannull, J., and Vieweg, J. Dendritic cells transfected with prostate specific antigen RNA induces PSA specific T cell responses in metastatic prostate cancers. J. Clin. Investig., 159: 2002.
8. McKiernan, J. M., Buttyan, R., Bander, N. H., de la Taille, A., Stifelman, M. D., Emanuel, E. R., Bagiella, E., Rubin, M. A., Katz, A. E., Olsson, C. A., and Sawczuk, I. S. The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9. Cancer (Phila.), 86: 492-497, 1999.
9. Suenaga, M., Soda, H., Oka, M., Yamaguchi, A., Nakatomi, K., Shiozawa, K., Kawabata, S., Kasai, T., Yamada, Y., Kamihira, S., Tei, C., and Kohno, S. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells. Int. J. Cancer, 97: 621-625, 2002.
10. Andrews, D. M., Leary, C. P., Hishii, M., Shen, J., and Kurnick, J. Use of single stranded conformational polymorphism (SSCP) for analysis of the T cell receptor. In: J. R. Oksenberg (ed.), The Antigen T Cell Receptor: Selected Protocols and Applications, pp. 326-365. Austin: Landes Bioscience, 1996.
11. Yassai, M., Naumova, E., and Gorski, J. Generation of TCR spectratypes by multiplex PCR for T cell repertoire analysis. In: J. R. Oksenberg (ed.), The Antigen T Cell Receptor: Selected Protocols and Applications., pp. 373-404. Austin: Landes Bioscience, 1996.
12. Pastorek, J., Pastorekova, S., Callebaut, I., Mornon, J. P., Zelnik, V., Opavsky, R., Zat'ovicova, M., Liao, S., Portetelle, D., Stanbridge, E. J., et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene, 9: 2877-2888, 1994.
13. Van Den Eynde, B. J., Gaugler, B., Probst-Kepper, M., Michaux, L., Devuyst, O., Lorge, F., Weynants, P., and Boon, T. A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription. J. Exp. Med., 190: 1793-1800, 1999.
14. Schamhorst, V., van der Eb, A. J., and Jochemsen, A. G. WT1 proteins: functions in growth and differentiation. Gene, 273: 141-161, 2001.
15. Zelle-Rieser, C., Barsoum, A. L., Sallusto, F., Ramoner, R., Rohrer, J. W., Holtl, L., Bartsch, G., Coggin, J. J., and Thurnher, M. Expression and immunogenicity of oncofetal antigen-immature laminin receptor in human renal cell carcinoma. J. Urol., 165: 1705-1709, 2001.
16. Heiser, A., Dahm, P., Yancey, D., Maurice, M., Boczkowski, D., Nair, S. K., Gilboa, E., and Vieweg, J. Human dendritic cells transfected with RNA encoding prostate specific antigen stimulate prostate specific CTL responses in vitro. J. Immunol., 164: 5508-5514, 2000.
17. Weissman, D., Ni, H., Scales, D., Dude, A., Capodici, J., McGibney, K., Abdool, A., Isaacs, S. N., Cannon, G., and Kariko, K. HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response. J. Immunol., 165: 4710-4717, 2000.
18. Ni, H., Capodici, J., Cannon, G., Communi, D., Boeynaems, J. M., Kariko, K., and Weissman, D. Extracellular mRNA induces dendritic cell activation by stimulating tumor necrosis factor-α secretion and signaling through a nucleotide receptor. J. Biol. Chem., 277: 12689-12696, 2002.
19. Su, Z., Vieweg, J., Weizer, A. Z., Dahm, P., Yancey, D., Turaga, V., Higgins, J., Boczkowski, D., Gilboa, E., and Dannull, J. Enhanced induction of telomerasespecific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product. Cancer Res., 62: 5041-5048, 2002.
20. Fallick, M. L., McDermott, D. F., LaRock, D., Long, J. P., and Atkins, M. B. Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma. J. Urol., 158: 1691-1695, 1997.
21. Jager, E., Ringhoffer, M., Altmannsberger, M., Arand, M., Karbach, J., Jager, D., Oesch, F., and Knuth, A. Immunoselection in vivo: independent loss of MHC class 1 and melanocyte differentiation antigen expression in metastatic melanoma. Int. J. Cancer, 71: 142-147, 1997.
22. Banchereau, J., Palucka, A. K., Dhodapkar, M., Burkeholder, S., Taquet, N., Rolland, A., Taquet, S., Coquery, S., Wittkowski, K. M., Bhardwaj, N., Pineiro, L., Steinman, R., and Fay, J. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res., 61: 6451-6458, 2001.
23. Schuler-Thurner, B., Schultz, E. S., Berger, T. G., Weinlich, G., Ebner, S., Woerl, P., Bender, A., Feuerstein, B., Fritsch, P. O., Romani, N., and Schuler, G. Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J. Exp. Med., 195: 1279-1288, 2002.
24. Gleave, M. E., Elhilali, M., Fradet, Y., Davis, I., Venner, P., Saad, F., Klotz, L. H., Moore, M. J., Paton, V., and Bajamonde, A. Interferon γ-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group. N. Engl. J. Med., 338: 1265-1271, 1998.
25. Fong, L., Brockstedt, D., Benike, C., Breen, J. K., Strang, G., Ruegg, C. L., and Engleman, E. G. Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy. J. Immunol., 167: 7150-7156, 2001.